Darlene M. Deptula-Hicks
CIK: 0001089409
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALDX
Aldeyra Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About DEPTULA-HICKS DARLENE M
DEPTULA-HICKS DARLENE M (SEC CIK 0001089409) files insider reports with the SEC as Director of Aldeyra Therapeutics, Inc. (ALDX).
Signal8 holds 2 ownership filings by DEPTULA-HICKS DARLENE M (1 Form 3, 1 Form 4), filed on Jun 11, 2026. Those filings report 2 transactions, the latest on Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DEPTULA-HICKS DARLENE M's filings is in LEXINGTON, MA.
Recent filings by DEPTULA-HICKS DARLENE M
- Jun 9, 2026: Grants or awards of ALDX derivative securities (2 lines, Form 4, code A).
Other insiders filing for Aldeyra Therapeutics, Inc. (ALDX)
- Miller-Rich Nancy, Director
- DOUGLAS RICHARD, Director
- Phillips Gary M., Director
- Clark William D, Director
- Walker Neal, Director
- Bronstein Ben, Director